Here, we provide a detailed methodology to isolate and assess cytotoxic function of natural killer cells from placentas by a colorimetric plate assay. The reduced uterine perfusion pressure rat model of placental ischemia was chosen to demonstrate the antibody-mediated isolation and assessment of the cytotoxic function of natural killer cells.
It is well known that decidual natural killer (NK) cells play a critical role in establishment and maintenance of normal pregnancy. Recent studies have demonstrated an altered population of circulating and decidual NK cells in women who suffer from adverse pregnancy complications such as recurrent miscarriage and preeclampsia. Studies from our group have shown that hypertension in pregnancy is associated with an increased population of activated NK cells in the placenta based on the expression of surface activation markers. This manuscript provides a detailed protocol to assess the cytotoxic function of NK cells isolated from placentas in a preeclampsia-like animal model of surgically induced placental ischemia. The following steps are described in detail: generation of single cell suspension, NK cell isolation, ex vivo stimulation, effector:target cell co-culture, and the cytotoxicity assay.
Preeclampsia is a hypertensive disorder of pregnancy characterized by fetal growth restriction, end organ damage and chronic immune activation. Chronic immune activation in women with preeclampsia leads to increased circulating and placental inflammatory cytokines, an imbalance in CD4+ T Cells populations, and an increased population of activated Natural Killer (NK) cells1. Studies recently published by our lab demonstrate a role for NK cells in causing some of the pathophysiology associated with preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model of preeclampsia. Using flow cytometry to measure surface expression of activation markers on NK cells, an increased population of activated NK cells in the circulation and placentas of RUPP rats compared to normal pregnant (NP) rats was observed2.
To confirm the flow cytometry observations, functional studies to assess the cytotoxic activity of NK cells isolated from the placentas of NP and RUPP rats were performed. There are several methods available for the assessment of cytotoxic function of cytotoxic CD8+ T cells and NK cells. The gold standard for functional cytotoxic analysis is the chromium release assay3. Other developed protocols utilized include flow cytometry4, image cytometry5, calcein release6, and most recently bioluminescence7. This video will provide a detailed protocol on using the well-established lactate dehydrogenase (LDH) release assay to measure cytotoxic function of NK cells using a commercially available LDH cytotoxicity assay kit.
All protocols were approved by the Institutional Animal Care and Use Committee at the University of Mississippi Medical Center. The care and handling of the animals were in accord with the National Institutes of Health guidelines for ethical animal treatment.
1. Lymphocyte Cell Isolation from Placentas
2. Isolation of Natural Killer Cells
3. Cytotoxicity Assay: Retrieving NK Cells or YAC1 from Culture or Passing Cells
NOTE: All steps must be conducted under the hood. All cell tubes must be kept on ice at all times.
4. Cytotoxicity Assay: Assay Protocol
5. Calculation of Results
Placental NK cells obtained from NP and RUPP rats were incubated for 5 h with target cells in their respective medias at a ratio of 50:1 (NK:target). Absorbance was recorded at 490 nm and the raw data is shown in Table 2. The average absorbance of the Culture Medium Background and the Volume Correction control wells were calculated. These averages were subtracted from the appropriate wells indicated in the manufacturer’s protocol and are represented in Table 3. The corrected values were then used to obtain the% cytotoxicity using the protocol provided by the manufacturer (Table 4).
1 | 2 | 3 | 4 | 5 |
TCS | VCC | ECSR-1 | ECSR-2 | ECSR-3 |
TCS | VCC | ECSR-1 | ECSR-2 | ECSR-3 |
TCS | VCC | ECSR-1 | ECSR-2 | ECSR-3 |
TCS | VCC | ECSR-1 | ECSR-2 | ECSR-3 |
TCM | CMB | EW-1 | EW-2 | EW-3 |
TCM | CMB | EW-1 | EW-2 | EW-3 |
TCM | CMB | EW-1 | EW-2 | EW-3 |
TCM | CMB | EW-1 | EW-2 | EW-3 |
Table 1: Assay Plate Layout. TCS = Target cell Spontaneous LDH Release (50 μL target cells + 50 μL target cell medium); TCM = Target Cell Maximum LDH Release (50 μL target cells + 50μL target cell medium); VCC = Volume Correction Control (50 μL target cell medium + 50 μL NK Cell medium); CMB = Culture Medium Background Control (50 μL target cell medium + 50 μL NK Cell medium); ECSR = Effector Cell Spontaneous Release (50 μL NK cells + 50 μL NK cells medium); EW = Experimental wells (50 μL target cells + 50 μL NK cells).
1 | 2 | 3 | 4 | 5 |
NP | RUPP | NP | ||
0.615 | 0.484 | 0.473 | 0.463 | 0.471 |
0.586 | 0.484 | 0.458 | 0.474 | 0.469 |
0.61 | 0.486 | 0.464 | 0.459 | 0.469 |
0.578 | 0.495 | 0.478 | 0.458 | 0.482 |
0.605 | 0.55 | 0.524 | 0.526 | 0.543 |
0.576 | 0.504 | 0.519 | 0.502 | 0.528 |
0.565 | 0.512 | 0.515 | 0.513 | 0.531 |
0.563 | 0.581 | 0.526 | 0.508 | 0.519 |
Table 2: Raw absorbance data of an assay plate containing the experimental controls in columns 1 and 2 and experimental wells to measure the cytotoxicity of placental NK cells from NP and RUPP rats against YAC1 target cells.
1 | 2 | 3 | 4 | 5 |
NP | RUPP | NP | ||
0.12775 | -0.01425 | -0.02425 | -0.01625 | |
0.09875 | -0.02925 | -0.01325 | -0.01825 | |
0.12275 | -0.02325 | -0.02825 | -0.01825 | |
0.09075 | -0.00925 | -0.02925 | -0.00525 | |
0.06825 | 0.03675 | 0.03875 | 0.05575 | |
0.03925 | 0.03175 | 0.01475 | 0.04075 | |
0.02825 | 0.02775 | 0.02575 | 0.04375 | |
0.02625 | 0.03875 | 0.02075 | 0.03175 |
Table 3. Corrected Absorbance. Absorbance of wells after subtraction of average absorbance of control wells according to the manufacturer’s protocol. Column 1, Wells 1-4, are TCS absorbances values - the average CMB absorbance value. Column 1, Wells 5-8, are the TCM absorbance values - the average VCC absorbance value.
NP | RUPP | NP | |
128.9916 | 108.8235 | 93.69748 | |
63.44538 | 118.9076 | 66.80672 | |
75.92593 | 72.75132 | 64.28571 | |
66.27907 | 63.17829 | 83.33333 | |
Average % Cytotoxicity | 83.66049 | 90.91518 | 77.03081 |
Table 4. Cytotoxicity Calculations. Average percent cytotoxicity of replicate samples of placental NK cells isolated from NP and RUPP rats.
There are a number of important key notes to consider for optimal results. The sterility of the cells utilized is very important. After collection of the placenta, it is important that preparation and isolation of the NK cells are performed under sterile conditions in a biosafety cabinet. Furthermore, because all cells release LDH upon cellular damage, care should be taken to obtain a high viability of NK cells after isolation and during the co-culture process. Too much spontaneous LDH release from the NK cells can often result in negative, unusable data
There are some aspects of this protocol that will be specific to the user and their needs. For example, there are various methods for isolation of mononuclear cells from placenta in addition to the methods in this article, such as mechanical and enzymatic disaggregation. Additionally, it is up the user to determine the optimal target cells number and effector:target ratio that will be suitable for their experiment. In our hands, 10,000 target cells and an effector:target ratio of 50:1 was determined to be optimal for our experiments. These numbers may change depending on the target cells chosen and on the tissue from which the NK cells are isolated. Other investigators have utilized this method to assess NK function of cells isolated from liver and spleen9. Therefore, this method can be employed in various areas of research, not just in studies of preeclampsia, as we have chosen to use it.
The gold standard for cytotoxicity assessment is the chromium release assay5. While this method is reliable and reproducible, the most obvious limitation is the use of radioactive exposure risk to personnel and radioactive disposal. Other, non-radioactive cytotoxicity assays such as the flow cytometry based and calcien release assays are reported to have comparable results to CRA6,10,11. However, flow-cytometry-based assays require additional specialized training of personnel in flow cytometry to run the assay. The LDH release assay doesn’t require any specialized training, as this test only requires simple pipetting to perform the assay. Additionally, while the LDH release assay can be utilized using standard spectroscopy or fluorescent detection, the calcien release and flow-cytometry-based methods require equipment capable of detecting fluorescence. Limitations of the LDH release assay include an underestimation of cell death due to incomplete release of LDH from damaged cells.
In this assay, the measurement of LDH released into the media occurs by an enzymatic reaction in which iodonitrotetrazolium (a tetrazolium salt) is converted into formazan (red in color). The absorbance is measured by standard spectroscopy and the amount of damaged cells in the culture is proportional to the intensity of the red color. This assay allows for accurate determination of damaged or injured cells in a sample. Finally, this colorimetric assay can also be used with other cell types to assay cytotoxicity occurring via cell-mediated as well as chemical-mediated mechanisms.
The authors have nothing to disclose.
This work was supported by the National Heart Lung and Blood Institute of the National Institutes of Health under grant R00HL130456, the National Institute of General Medical Sciences of the National Institutes of Health under award P20GM104357, and by the Mississippi INBRE, funded by an Institutional Development Award (IDeA) from the National Institutes of General Medical Sciences of the National Institutes of Health under grant number P20GM103476. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
1.5 mL Eppendorf tube | Fisher | 5408129 | |
100 µL Filter | Fisher | 22363549 | Nylon Mesh |
15 mL conical tube | Fisher | 0553859A | |
3 mL syringe | Fisher | 14823436 | |
50 mL conical tube | Fisher | 7203510 | |
6-well cell culture plate | Corning | 720083 | |
96-well Tissue Culture Plate | CELLTREAT | 229190 | Sterile, Round Bottom |
AOPI | Nexcelom | CS201065ML | |
Cell scraper | Fisher | 8100241 | |
Cellometer Disposable Counting Chambers | Nexcelom | CHT4-SD100 | |
Cellometer Vision Image Cytometer | Nexcelom | N/A | |
Cytotox 96 Non-Radioactive Cytotoxicity Assay Kit | Promega | G1780 | |
Dynabeads Flowcomp Flexi Kit | Invitrogen | 11061D | |
DynaMag-2 Magnet | Invitrogen | 12321D | |
EDTA | Sigma Aldrich | EDS-100G | |
FBS | Atlanta Biologicals | S11150H | |
Flow Cytometry Tube | Corning | 352008 | |
Lymphoprep | Fisher | NC0460539 | Density gradient medium; 4 x 250 mL |
PBS | Fisher | SH3025801 | 10 x 500 mL |
Penicillin/Streptomycin | Gibco | 15140122 | |
Petri dishes | Fisher | 9720500 | Without Pad |
Purified Mouse anti-Rat CD161a | BD Biosciences | 555006 | |
Purified Mouse anti-Rat CD3 | BD Biosciences | 554829 | |
Recombinant Rat IL-2 | R&D Systems | 502-RL | |
RPMI | Gibco | 11875135 | 1640 Medium |
T25 flask | Corning | 430639 | |
Trypsin | ThermoFisher | 15090046 | |
YAC-1 cell | ATCC | TIB-160 |